We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.84B
AUM Growth
+$226M
Cap. Flow
+$18.1M
Cap. Flow %
0.98%
Top 10 Hldgs %
36.21%
Holding
2,856
New
200
Increased
717
Reduced
1,072
Closed
193
Avg Time Held Equity + Options
2.5 years
Top 10 Avg Time Held Equity + Options
1.7 years
Top 20 Avg Time Held Equity + Options
1.8 years
Avg Time Held Equity only
2.5 years
Top 10 Avg Time Held Equity only
1.7 years
Top 20 Avg Time Held Equity only
1.8 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 54.33%
2 Technology 13.72%
3 Financials 8.08%
4 Healthcare 7.07%
5 Consumer Discretionary 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ACB icon
2526
Aurora Cannabis
ACB
$260M
– –
0
– –
2020 Q4
0 quarters
ACHC icon
2527
Acadia Healthcare
ACHC
$2.89B
$0 ﹤0.01%
3
-311
-99% -$12.4K
2017 Q4
12 quarters
ADNT icon
2528
Adient
ADNT
$1.4B
$0 ﹤0.01%
2
– –
2017 Q1
15 quarters
AHRT icon
2529
AH Realty Trust
AHRT
$445M
– –
-24
Closed – –
AIV icon
2530
Aimco
AIV
$244M
$0 ﹤0.01%
88
-993
-92% -$4.41K
2016 Q4
16 quarters
AKR icon
2531
Acadia Realty Trust
AKR
$2.54B
– –
-91
Closed -$1K –
ALKS icon
2532
Alkermes
ALKS
$6.73B
$0 ﹤0.01%
14
– –
2020 Q1
3 quarters
ALX icon
2533
Alexander's
ALX
$1.2B
– –
-4
Closed -$1K –
OSG icon
2534
Octave Specialty Group
OSG
$207M
$0 ﹤0.01%
16
– –
2020 Q1
3 quarters
AMR icon
2535
Alpha Metallurgical Resources
AMR
$2.15B
$0 ﹤0.01%
3
– –
2019 Q1
7 quarters
ANF icon
2536
Abercrombie & Fitch
ANF
$6.45B
– –
-443
Closed -$6K –
ARCO icon
2537
Arcos Dorados Holdings
ARCO
$1.7B
– –
-1,414
Closed -$6.46K –
ARES icon
2538
Ares Management
ARES
$25.9B
$0 ﹤0.01%
5
– –
2020 Q1
3 quarters
ARVN icon
2539
Arvinas
ARVN
$468M
– –
-167
Closed -$4K –
ASIX icon
2540
AdvanSix
ASIX
$446M
$0 ﹤0.01%
20
-11
-35% -$188
2016 Q4
16 quarters
ASPS icon
2541
Altisource Portfolio Solutions
ASPS
$63.8M
– –
-313
Closed -$32K –
AVTX icon
2542
Avalo Therapeutics
AVTX
$644M
– –
0
– –
2020 Q1
3 quarters
AXGN icon
2543
Axogen
AXGN
$2.09B
– –
-3,002
Closed -$35K –
AZUL icon
2544
DELISTED
Azul
AZUL
$0 ﹤0.01%
1
– –
2020 Q1
3 quarters
BAC.PRL icon
2545
Bank of America Series L
BAC.PRL
$3.63B
– –
-241
Closed -$359K –
BATRA icon
2546
Atlanta Braves Holdings Series A
BATRA
$3.51B
$0 ﹤0.01%
11
– –
2020 Q2
2 quarters
BCDA icon
2547
BioCardia
BCDA
$14.2M
$0 ﹤0.01%
+3
New +$120
2020 Q4
0 quarters
BF.A icon
2548
Brown-Forman Class A
BF.A
$13.4B
$0 ﹤0.01%
6
– –
2020 Q2
2 quarters
BKH icon
2549
Black Hills Corp
BKH
$5.79B
– –
-98
Closed -$5K –
BLMN icon
2550
Bloomin' Brands
BLMN
$850M
– –
-798
Closed -$12K –

Similar funds

Parallel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Parallel Advisors held 2,856 positions worth $1.84B, up 14% from $1.62B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q4 2020 filing shows 200 new, 717 increased, 1,072 reduced and 193 closed positions. Its largest new stake was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M. The largest sale was Microsoft, an estimated $18.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, down from 56% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q4 2020 buy was Inari Medical, Inc. Common Stock: 59,852 shares worth $5.22M.
  • Parallel Advisors added most to iShares US Treasury Bond ETF in Q4 2020, an estimated $14.5M increase.
  • Parallel Advisors's biggest Q4 2020 reduction was Microsoft, cutting an estimated $18.3M.
  • Parallel Advisors fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $926K.
  • Parallel Advisors's ten largest holdings make up 36% of its $1.84B portfolio in Q4 2020.
  • Parallel Advisors opened 200 new positions and closed 193 in Q4 2020.
  • Parallel Advisors's portfolio value rose 14% quarter-over-quarter to $1.84B.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.